A recent study found that continued therapy with a combination regimen until disease progression improves outcomes in patients with newly diagnosed multiple myeloma who are not eligible for ASCT. READ MORE

Special Reports

The Special Report, "Clinical Pathways to Address the Challenges of Treatment Resistance and Relapse in Multiple Myeloma," reviews the challenges associated with different phases of treatment for multiple myeloma and how clinical pathways can support physicians’ decision-making.

READ MORE

The Special Report, "Clinical Pathways to Address the Challenges of Treatment Resistance and Relapse in Multiple Myeloma," reviews the challenges associated with different phases of treatment for multiple myeloma and how clinical pathways can support physicians’ decision-making.

READ MORE

This report reviews the complex nature of multiple myeloma treatment, the current landscape of clinical practice guidelines and treatment pathways, and economic considerations for treatment.

READ MORE